Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
OKYO OKYO Pharma
2.320+0.050+2.20%
Close
02/03 16:00 ET
2.3200.0000.00%
Post Mkt Price 02/03 16:27 ET
High
2.480
Open
2.220
Turnover
12.97K
Low
2.200
Pre Close
2.270
Volume
5.59K
Post-Market
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
12 Health Care Stocks Moving In Tuesday's After-Market Session
GainersTransCode Therapeutics (NASDAQ:RNAZ) stock moved upwards by 49.2% to $1.12 during Tuesday's after-market session. Today's trading volume for this security ended up closing at 2.8 million shares
12 Health Care Stocks Moving In Monday's After-Market Session
GainersNymox Pharmaceutical (NASDAQ:NYMX) shares rose 21.8% to $0.5 during Monday's after-market session. The market value of their outstanding shares is at $45.2 million. Brainstorm Cell (NASDAQ:BCLI
12 Health Care Stocks Moving In Tuesday's Intraday Session
GainersCelyad Oncology (NASDAQ:CYAD) stock moved upwards by 150.2% to $2.0 during Tuesday's regular session. Trading volume for Celyad Oncology's stock is 50.4 million as of 12:30 EST. This is 563061.
12 Health Care Stocks Moving In Monday's Intraday Session
GainersSmileDirectClub (NASDAQ:SDC) stock increased by 47.0% to $0.71 during Monday's regular session. SmileDirectClub's stock is trading at a volume of 29.4 million shares as of 12:30 EST. This is 15
Seagen (NASDAQ:SGEN) Vs. OKYO Pharma (NASDAQ:OKYO) Financial Survey
Seagen (NASDAQ:SGEN – Get Rating) and OKYO Pharma (NASDAQ:OKYO – Get Rating) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of th
Reviewing Seagen (NASDAQ:SGEN) and OKYO Pharma (NASDAQ:OKYO)
OKYO Pharma (NASDAQ:OKYO – Get Rating) and Seagen (NASDAQ:SGEN – Get Rating) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength
OKYO Pharma (LON:OKYO) Stock Price Down 11.1%
OKYO Pharma Limited (LON:OKYO – Get Rating)'s stock price was down 11.1% during mid-day trading on Tuesday . The company traded as low as GBX 2 ($0.02) and last traded at GBX 2 ($0.02). Approximately
Okyo Pharma Shares Jump as FDA Clears Dry Eye Disease Candidate for Phase 2 Study
By Kyle Morris Shares in Okyo Pharma Ltd. jumped 22% on Thursday after the company said it has received clearance from the U.S. Food and Drug Administration to start a Phase 2 clinical study of OK-10
Okyo Pharma Gets US FDA Approval to Launch Mid-Stage Trial For Dry Eye Disease Therapy
02:30 AM EST, 12/22/2022 (MT Newswires) -- Okyo Pharma (OKYO.L) said the US Food and Drug Administration approved its investigational new drug request to launch a phase 2 trial for dry eye disease tre
OKYO Pharma (NASDAQ:OKYO) Trading Down 2.9%
OKYO Pharma Limited (NASDAQ:OKYO – Get Rating)'s share price was down 2.9% during mid-day trading on Wednesday . The stock traded as low as $2.11 and last traded at $2.15. Approximately 1,731 shares
Company Overview
More
OKYO Pharma Ltd operates as a biopharmaceutical company, which engages in the development of therapeutics for inflammatory eye diseases and chronic pain. It targets to cure and prevent the following conditions: dry eye disease, non-infectious anterior uveitis, allergic conjunctivitis, and ocular pain. The company was founded on July 4, 2007 and is headquartered in London, the United Kingdom.
CEO： Dr. Gary S. Jacob, PhD
Market： NASDAQ
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet